Hwabao CSI Medical ETF (SHA:512170)
0.3820
-0.0060 (-1.55%)
At close: Sep 26, 2025
-1.55% (1Y)
Assets | 26.24B |
Expense Ratio | 0.60% |
PE Ratio | 27.01 |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +19.38% |
Volume | 1,453,439,900 |
Open | 0.3860 |
Previous Close | 0.3880 |
Day's Range | 0.3810 - 0.3870 |
52-Week Low | 0.2780 |
52-Week High | 0.4030 |
Beta | n/a |
Holdings | 85 |
Inception Date | May 20, 2019 |
About 512170
512170.SS was created on 2019-05-20 by Hwabao. The fund's investment portfolio concentrates primarily on health care equity. The index of the target is closely tracked, and the tracking deviation and tracking error are minimized
Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 512170
Provider Hwabao
Index Tracked CSI Medical Index Yield - Benchmark TR Gross
Performance
512170 had a total return of 19.38% in the past year, including dividends. Since the fund's inception, the average annual return has been -14.03%.
Top 10 Holdings
54.01% of assetsName | Symbol | Weight |
---|---|---|
WuXi AppTec Co., Ltd. | 603259 | 10.79% |
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | 300760 | 9.47% |
Shanghai United Imaging Healthcare Co., Ltd. | 688271 | 8.01% |
Aier Eye Hospital Group Co., Ltd. | 300015 | 7.38% |
Hangzhou Tigermed Consulting Co., Ltd | 300347 | 3.51% |
Imeik Technology Development Co.,Ltd. | 300896 | 3.38% |
APT Medical Inc. | 688617 | 3.14% |
Shenzhen New Industries Biomedical Engineering Co., Ltd. | 300832 | 2.84% |
Pharmaron Beijing Co., Ltd. | 300759 | 2.76% |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 002223 | 2.72% |